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Abstract 
Elderly people in nursing home communities are vulnerable to contagious infections, 
including the influenza virus. Systematic anti-influenza vaccination is an important preventive 
measure; however, vaccination does not provide absolute protection. We report an outbreak of 
influenza A infection in a well-vaccinated nursing home population. Several factors can 
facilitate the occurrence of this type of outbreak. This report mainly addresses the discrepancy 







In the elderly patient, influenza is a severe respiratory affliction that is responsible for 
substantial morbidity and mortality related to bacterial superinfection and acute 
decompensation. The risks of influenza are even more severe for the elderly patient who has 
an underlying disease and/or is institutionalised1. 
 
Materials and Methods 
The described outbreak occurred in a residence home for elderly people (Maison de Repos 
pour Personnes Agées; rusthuis) in a rural area of Belgium. The facility accommodates 62 
residents aged 50−100 years (41 women, 21 men; average age, 80.9 ±9.5 years). Residents are 
under the care of their own, freely selected general practitioner (GP). There is no coordinating 
doctor because the establishment does not have the status of nursing home (in Belgium: MRS 
Maison de Repos et de Soins,; verzorgingstehuis). The 33 GPs who share the medical care of 
the residents carried out influenza vaccination during the autumn of 2004, using vaccines 
according to WHO recommendations. At the beginning of December, the vaccination rate of 
residents exceeded 98%, and only one resident had not received a vaccine. None of the 26 
members of the institutional staff was vaccinated against influenza.  
Between March 9 and 21, 2005, 32 (23 women and 9 men) of the 62 residents showed a 
common symptomatology: hyperthermia, asthenia, and cough. Moreover, 39% of the patients 
presented expectorations, 32% had rhinorrhea, 29% had cephalea, and 9% had digestive 
symptoms. Six people died from respiratory insufficiency. Table 1 shows the chronology of 
occurrence of the diseases in this establishment and the age and gender of the affected 
residents and deceased patients. 
The incidence of this outbreak among residents was 51.6%, and the death rate of 
affected patients was 18.7%. Whereas the average age of the residents was 80.9 years, that of 
the affected population was 81.2 ± 10.5 years, and that of the deceased patients was 88.1  ± 
5.2 years. Among the 26 members of the staff, 5 presented comparable symptoms, as did a GP 
a short time after caring for an infected patient. Each patient benefited from the care of their 
own GP, who was summoned by the personnel. No GP conducted nasopharyngeal smears. 
There was no concerted action regarding the diagnosis during the outbreak. The influenza 
diagnosis was mentioned by only one GP, who, on the seventh day of the outbreak (March 
15), initiated oseltamivir as treatment (75 mg, 2/day) for two residents and as prophylaxis (75 
mg, 1/day) for three other patients. The diagnosis of bronchitis was mentioned by GPs of 13 
patients. All of the infected patients who presented with fever and cough were treated with 
antibiotics.  
Three patients were hospitalised and died. The hospitalisation reports mentioned 
unfavourable evolution of a pulmonary infection, without further precision. The affected 
people were confined to their rooms, and, by the initiative of the head nurse, the decision was 
made to stop all community meals on March 17−18. No declaration to the health authorities 
was made by the concerned GPs, hospital doctors, or residence home management or 
personnel. No comparable outbreak was reported in the area, at least to the knowledge of the 
authors and the 19 involved GPs.  
Two of the authors, GPs who treated affected patients, initiated an etiologic 
investigation a posteriori. With the joint assent of the patients (or their representatives) and 
GPs, two blood samples were obtained from 21 of the 32 affected patients on March 31 and 
April 16. The samples were analysed at the laboratory of microbiology services at the CHU of 
Liege (Prof. P. De Mol). At that time after the outbreak, only a serologic diagnosis a 
posteriori was possible. A serologic response to the following respiratory pathogens, 
including pathogens that were potentially responsible for outbreaks, was investigated by an 
immuno-enzymatic method: influenza A and B (IgA and IgG), parainfluenza (IgA and IgG), 
adenovirus (IgA and IgG), RSV (IgM), Chlamydia pneumoniae (IgA and IgG - MEDAK - 
ELISA), and Mycoplasma pneumoniae (IgM and IgG – ELISA-VIRION). Legionella (total Ig 
– I.F.I.) was investigated by immunofluorescence. For each patient, the first serum sample 
was taken 10−21 days after the beginning of the outbreak, and the second sample was 
obtained 2 weeks later. A complementary specific serologic analysis of various strains of the 
influenza virus was carried out at the laboratory of the National Centre of Influenza in 




Serologic tests for various respiratory pathogenic agents 
All samples were positive for anti-influenza A IgG (Elisa-IBL), with an average IgG titre of 
903 u/ml. For 16 patients, two or several consecutive sera were titrated, and six "influenza A" 
seroconversions were observed. For nine other patients, the titre of the first serum was already 
high. These results support an outbreak of recent influenza A infections. However, the 
presence of anti-influenza IgA was never detected. No specific immune response was detected 
against the other infectious agents.  
 
Complementary serologic "influenza” tests 
Specific serologic tests of influenza A and B virus that were carried out by the reference 
method (inhibition of haemagglutination) showed high titres against the strain influenza A 
New York, X-157 (H3N2) for 12 of the 17 evaluated patients and two of the three staff 
members. Of the 13 patients for whom several consecutive sera were titrated, seven 
seroconversions were observed. The major serologic answer to this strain of laboratory 
influenza A indicated a response to the related circulating strain A/California/7/2004 (H3N2).  
 Discussion 
The present observation shows once again that the nursing home population is not safe from 
an influenza outbreak, even if all residents are well vaccinated2,3. The effectiveness of a 
seasonal vaccine depends on the correspondence of its antigenic composition with circulating 
strains. The time between vaccination and viral contact is important: after a 6-month time 
lapse, vaccine immunity against influenza erodes and loses its protective effectiveness1,2,3. 
For this reason, the Centres for Diseases Control and Prevention (U.S.A.) does not 
recommend vaccination before October because of the loss of immunity that can be observed 
in the spring4. Moreover, in the elderly person, other elements play substantial roles in 
immunity, such as the reduced capacity of immunological response with age, lack of physical 
activity, and nutritional deficits1.  
The occurrence of the outbreak at the end of the influenza season, several months after 
vaccination of the residents (6 months for the first residents vaccinated in September), the 
absence of vaccine coverage of the nursing personnel, and institutional living could have 
favoured the occurrence of this outbreak5. However, the complementary serologic results 
indicated that the strain responsible for this outbreak, which was influenza 
A/California/7/2004 (H3N2)-like, was distinct from the vaccine strains recommended by the 
World Health Organisation and was not included in the vaccine administered in 2004−2005. 
Consequently, acquired vaccine protection was likely very low.  
The influenza vaccination guidelines were unequally respected in this nursing home. 
The vaccination rate of the residents was optimal (98%), according to the literature6; on the 
other hand, the total absence of vaccination of the nursing personnel (0%) is a matter of 
concern. Van Ranst showed that in Flanders in 2002, the vaccine coverage of health 
professionals was rather poor (~20%)7. Canadian and American publications have reported 
vaccine coverage of 36−37% of health care professionals. Vaccine efficacy in the prevention 
of deaths in nursing home populations has been proven if the health care professional 
vaccination rate reaches 50−60%8,9.  In the situation we described, the virus may have been 
introduced by a visitor or a staff member. The horizontal transmission of these flu infections 
between residents could have been enhanced by the activities of the five staff members who 
developed the disease. Indeed, some of them continued their professional occupation even 
after they presented symptoms.  
The attack and death rates were 51.6% and 18.7%, respectively. Publications 
describing influenza outbreaks in long-stay institutions for elderly people have reported attack 
rates of 10−70% and death rates that reach 50%7,8,10,11,12,13. However, it is difficult to compare 
observations relating to different circumstances of care and very different elderly populations. 
Nevertheless, the extent of the outbreak poses questions regarding the way in which this 
outbreak in a elderly community was managed, mainly about the absence of coordination 
between health care workers and GPs. This lack of collaboration can explain the absence of a 
collective diagnosis and, consequently, the lack of appropriate treatment and adequate 
hygienic and prophylactic measures.  
The diagnosis of influenza solely on the basis of clinical signs remains difficult14,15,16. 
Our observation confirms this fact: only one GP administered an antiviral treatment, 
mentioning an influenza diagnosis. No doctor used viral culture, PCR analysis, or antigen 
detection from nasopharyngeal smears, the effectiveness of which is well proven17,18,19. These 
diagnostic interventions are cost-effective in long-term care facilities and are mainly 
recommended in the case of outbreaks of viral infection in a closed community20 but not in 
every individual case of influenza. The effectiveness of oseltamivir treatment in similar 
circumstances is no longer questioned20,21,22,23,24.  At that time of the year the GPs probably 
did not expect to be confronted with an influenza outbreak; however, the weekly bulletin of 
the Belgian National Centre of Influenza of the Scientific Institute of Public Health clearly 
mentioned cases of influenza infection at this time25. GPs should remember that influenza 
virus can cause outbreaks throughout the year, even in the summer. The use of neuraminidase 
inhibitors for treatment and for pre- and post-exposure prophylaxis could have helped to 
confine this outbreak23. 
With regard to the published guidelines, the following preventive measures within the 
institution are recommended to control the outbreak: isolation of patients, restricted visits, the 
use of masks, disinfection of the hands, strict adherence to measures of environmental 
hygiene, rapid ousting of the affected staff members, and discontinuation of all collective 
activities26,27,28. The Belgian legislation related to MRS entrusts a coordinating GP with 
responsibilities regarding the management of outbreaks. These legal provisions are not 
applicable to MRPA, but the absence of management and the consequences of the outbreak 
described herein demonstrate the importance of a coordinating doctor in this type of 
institution. Influenza outbreak appears on the list of notifiable diseases in Belgium29. Thus, 
the health authorities should have been contacted because they are the only ones who are 
legally entitled to manage an outbreak situation of this type. 
 
Conclusions 
We have described the effects of a community outbreak, which was most likely due to an 
influenza A virus similar to A/California/7/2004 (H3N2), in a well-vaccinated residence home 
population. Whereas the international community is preparing for a possible pandemic related 
to H5N1 influenza virus, residence homes for elderly people in Belgium are likely unprepared 
to handle this type of crisis. Our observations indicate the need for targeted training of GPs 
about influenza. This training should emphasize topics such as clinical signs, methods of rapid 
diagnosis (PCR detection and antigen detection), prophylactic treatments, and preventive 
measures. It is also important to remind GPs that vaccination does not provide total protection 
due to a possible incomplete match between the vaccine strains and the circulating strains. 
Also, the protective effect of influenza vaccine erodes 6 months after vaccination, and the 
immunization response of elderly people is often low. The present report demonstrated once 
again that an influenza outbreak can occur at the end of the “influenza season”. In fact, 
influenza infections can occur throughout the year, even in the summer. The roles of the GP 
with regard to community health in Belgium, and in particular in residence homes, certainly 
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Table 1. Dates when flu symptoms occurred. The numbers correspond to the ages of the 
affected residents. These figures are underlined for female patients, and deceased patients 
are indicated in bold. 
Date 
March 9 10 11 12 13 14 15 16 17 18 19 20 21 
 87 79 90  96 84 75 82 82 85 80  81 
 84  88  71 86 72 84 85 87    
   92  82 50 59 81 91     
       67 62 93     
       86  95     
       81       
       83       
 
